Cargando…

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

Pathology registers can be a useful tool to overcome obstacles in the identification and management of familial hypercholesterolemia since childhood. In 2018, the LIPIGEN pediatric group was constituted within the Italian LIPIGEN study to focus on FH subjects under 18 years. This work aimed at discu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gazzotti, Marta, Casula, Manuela, Bertolini, Stefano, Capra, Maria Elena, Olmastroni, Elena, Catapano, Alberico Luigi, Pederiva, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251337/ https://www.ncbi.nlm.nih.gov/pubmed/35795214 http://dx.doi.org/10.3389/fgene.2022.912510

Ejemplares similares

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group
por: Gazzotti, Marta, et al.
Publicado: (2023)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023)

Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group
por: Pederiva, Cristina, et al.
Publicado: (2023)

Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN)
por: Baragetti, Andrea, et al.
Publicado: (2021)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022)

Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study
por: Galimberti, Federica, et al.
Publicado: (2022)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
por: Olmastroni, Elena, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
por: Olmastroni, Elena, et al.
Publicado: (2023)

Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy
por: Galimberti, Federica, et al.
Publicado: (2022)

Adherence to lipid-lowering treatment: the patient perspective
por: Casula, Manuela, et al.
Publicado: (2012)

Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
por: Mattavelli, Elisa, et al.
Publicado: (2023)

Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies
por: Casula, Manuela, et al.
Publicado: (2022)

Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions—The EDU.RE.DRUG Project
por: Galimberti, Federica, et al.
Publicado: (2022)

Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges
por: Banderali, Giuseppe, et al.
Publicado: (2022)

A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: design and rationale of the EDU.RE.DRUG study
por: Casula, Manuela, et al.
Publicado: (2020)

Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia
por: Curia, Maria Cristina, et al.
Publicado: (2022)

Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
por: Cicolari, Stefania, et al.
Publicado: (2021)

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Correction: Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations
por: Mattavelli, Elisa, et al.
Publicado: (2022)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
por: D’Erasmo, Laura, et al.
Publicado: (2022)

Editorial: Rare dyslipidemias
por: Sadiq, Fouzia, et al.
Publicado: (2023)

Prevention starts from the crib: the pediatric point of view on detection of families at high cardiovascular risk
por: Capra, Maria Elena, et al.
Publicado: (2021)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Genetics of Familial Hypercholesterolemia: New Insights
por: Vrablik, Michal, et al.
Publicado: (2020)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic
por: Galimberti, F., et al.
Publicado: (2022)

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
por: Vuorio, Alpo, et al.
Publicado: (2021)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting
por: Tragni, Elena, et al.
Publicado: (2021)

Nutritional Treatment in a Cohort of Pediatric Patients with Familial Hypercholesterolaemia: Effect on Lipid Profile
por: Capra, Maria Elena, et al.
Publicado: (2022)

Familial Hypercholesterolemia in Russia: Three Decades of Genetic Studies
por: Vasilyev, Vadim, et al.
Publicado: (2020)

PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
por: Guo, Qianyun, et al.
Publicado: (2020)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_es35stvq7bg7urf2gm8npdcsv8